Benchmark cuts Medicine Man share target on Q4 miss, DEA cannabis resched uncertainty
Benchmark cuts Medicine Man share target on Q4 miss, DEA cannabis resched uncertainty
On Thursday, Benchmark adjusted its outlook on Medicine Man Technologies (OTC: SHWZ), reducing the share price target to $2.50 from the previous $3.00, while still holding to a Buy rating on the stoc…